Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to 115414.7%.

  • Molecular Partners Ag's Return on Capital Employed fell 1151856100.0% to 115414.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 115414.7%, marking a year-over-year decrease of 1151856100.0%. This contributed to the annual value of 0.0% for FY2024, which is 0.0% changed from last year.
  • Per Molecular Partners Ag's latest filing, its Return on Capital Employed stood at 115414.7% for Q3 2025, which was down 1151856100.0% from 0.13% recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Return on Capital Employed registered a high of 1720904.66% during Q3 2022, and its lowest value of 115414.7% during Q3 2025.
  • Its 5-year average for Return on Capital Employed is 160095.04%, with a median of 2.92% in 2025.
  • Examining YoY changes over the last 5 years, Molecular Partners Ag's Return on Capital Employed showed a top increase of 93797700bps in 2023 and a maximum decrease of 2000000000bps in 2023.
  • Quarter analysis of 5 years shows Molecular Partners Ag's Return on Capital Employed stood at 706.87% in 2021, then crashed by -1427bps to 9378.66% in 2022, then skyrocketed by 100bps to 1.1% in 2023, then plummeted by -9683bps to 105.57% in 2024, then crashed by -109221bps to 115414.7% in 2025.
  • Its Return on Capital Employed stands at 115414.7% for Q3 2025, versus 0.13% for Q2 2025 and 111.01% for Q1 2025.